Feedback / Questions
Keytruda (pembrolizumab) - Merck (MSD)
NG-350A - Akamis Bio
http://clinicaltrials.gov/ct2/show/NCT05165433
Aug 2, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next